Filament is working on a medical-grade version of ayahuasca containing standardized, measurable amounts of its active ingredients. Lightburn hopes that this will open the doors for clinical trials on ayahuasca to be conducted, and they are working on FDA-approved trials for 2023.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…